vs

Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and PROGRESS SOFTWARE CORP (PRGS). Click either name above to swap in a different company.

P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $252.7M, roughly 1.5× PROGRESS SOFTWARE CORP). PROGRESS SOFTWARE CORP runs the higher net margin — 10.2% vs -19.6%, a 29.8% gap on every dollar of revenue. On growth, PROGRESS SOFTWARE CORP posted the faster year-over-year revenue change (17.5% vs 3.8%). Over the past eight quarters, PROGRESS SOFTWARE CORP's revenue compounded faster (17.0% CAGR vs -0.5%).

P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.

Progress Software Corporation develops and sells enterprise software products including application development platforms, data connectivity tools, and digital experience solutions. It serves global enterprise clients across finance, healthcare, manufacturing, retail and other sectors, helping organizations build scalable, high-performance business applications and streamline operational workflows.

PIII vs PRGS — Head-to-Head

Bigger by revenue
PIII
PIII
1.5× larger
PIII
$384.8M
$252.7M
PRGS
Growing faster (revenue YoY)
PRGS
PRGS
+13.7% gap
PRGS
17.5%
3.8%
PIII
Higher net margin
PRGS
PRGS
29.8% more per $
PRGS
10.2%
-19.6%
PIII
Faster 2-yr revenue CAGR
PRGS
PRGS
Annualised
PRGS
17.0%
-0.5%
PIII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PIII
PIII
PRGS
PRGS
Revenue
$384.8M
$252.7M
Net Profit
$-75.5M
$25.7M
Gross Margin
81.6%
Operating Margin
-40.0%
15.2%
Net Margin
-19.6%
10.2%
Revenue YoY
3.8%
17.5%
Net Profit YoY
-28.8%
2144.6%
EPS (diluted)
$-23.08
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PIII
PIII
PRGS
PRGS
Q4 25
$384.8M
$252.7M
Q3 25
$345.3M
$249.8M
Q2 25
$355.8M
$237.4M
Q1 25
$373.2M
$238.0M
Q4 24
$370.7M
$215.0M
Q3 24
$362.1M
$178.7M
Q2 24
$379.2M
$175.1M
Q1 24
$388.5M
$184.7M
Net Profit
PIII
PIII
PRGS
PRGS
Q4 25
$-75.5M
$25.7M
Q3 25
$-31.6M
$19.4M
Q2 25
$-20.4M
$17.0M
Q1 25
$-20.5M
$10.9M
Q4 24
$-58.6M
$1.1M
Q3 24
$-46.5M
$28.5M
Q2 24
$-12.0M
$16.2M
Q1 24
$-18.7M
$22.6M
Gross Margin
PIII
PIII
PRGS
PRGS
Q4 25
81.6%
Q3 25
81.0%
Q2 25
80.1%
Q1 25
80.6%
Q4 24
83.0%
Q3 24
83.7%
Q2 24
81.7%
Q1 24
82.2%
Operating Margin
PIII
PIII
PRGS
PRGS
Q4 25
-40.0%
15.2%
Q3 25
-12.8%
17.6%
Q2 25
-9.6%
16.3%
Q1 25
-10.2%
13.6%
Q4 24
-37.4%
10.0%
Q3 24
-29.5%
22.6%
Q2 24
-8.3%
15.5%
Q1 24
-11.3%
19.0%
Net Margin
PIII
PIII
PRGS
PRGS
Q4 25
-19.6%
10.2%
Q3 25
-9.1%
7.8%
Q2 25
-5.7%
7.2%
Q1 25
-5.5%
4.6%
Q4 24
-15.8%
0.5%
Q3 24
-12.8%
15.9%
Q2 24
-3.2%
9.2%
Q1 24
-4.8%
12.3%
EPS (diluted)
PIII
PIII
PRGS
PRGS
Q4 25
$-23.08
$0.59
Q3 25
$-9.67
$0.44
Q2 25
$-6.23
$0.39
Q1 25
$-6.28
$0.24
Q4 24
$-23.13
$0.01
Q3 24
$-15.70
$0.65
Q2 24
$-7.37
$0.37
Q1 24
$-7.86
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PIII
PIII
PRGS
PRGS
Cash + ST InvestmentsLiquidity on hand
$25.0M
$94.8M
Total DebtLower is stronger
$228.4M
$1.4B
Stockholders' EquityBook value
$-155.2M
$478.3M
Total Assets
$656.6M
$2.5B
Debt / EquityLower = less leverage
2.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PIII
PIII
PRGS
PRGS
Q4 25
$25.0M
$94.8M
Q3 25
$37.7M
$99.0M
Q2 25
$38.6M
$102.0M
Q1 25
$40.1M
$124.2M
Q4 24
$38.8M
$118.1M
Q3 24
$63.0M
$232.7M
Q2 24
$73.1M
$190.4M
Q1 24
$27.3M
$133.2M
Total Debt
PIII
PIII
PRGS
PRGS
Q4 25
$228.4M
$1.4B
Q3 25
$252.8M
$1.4B
Q2 25
$182.0M
$1.5B
Q1 25
$171.1M
$1.5B
Q4 24
$108.9M
$1.5B
Q3 24
$133.2M
Q2 24
$133.1M
Q1 24
$118.1M
Stockholders' Equity
PIII
PIII
PRGS
PRGS
Q4 25
$-155.2M
$478.3M
Q3 25
$-18.7M
$477.7M
Q2 25
$44.5M
$452.7M
Q1 25
$63.3M
$431.8M
Q4 24
$75.9M
$438.8M
Q3 24
$120.5M
$425.6M
Q2 24
$166.8M
$401.7M
Q1 24
$146.6M
$461.7M
Total Assets
PIII
PIII
PRGS
PRGS
Q4 25
$656.6M
$2.5B
Q3 25
$683.6M
$2.4B
Q2 25
$731.6M
$2.4B
Q1 25
$783.9M
$2.5B
Q4 24
$783.4M
$2.5B
Q3 24
$833.3M
$1.6B
Q2 24
$892.8M
$1.6B
Q1 24
$855.9M
$1.5B
Debt / Equity
PIII
PIII
PRGS
PRGS
Q4 25
2.93×
Q3 25
2.97×
Q2 25
4.09×
3.22×
Q1 25
2.71×
3.50×
Q4 24
1.43×
3.48×
Q3 24
1.11×
Q2 24
0.80×
Q1 24
0.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PIII
PIII
PRGS
PRGS
Operating Cash FlowLast quarter
$-25.7M
$62.8M
Free Cash FlowOCF − Capex
$59.9M
FCF MarginFCF / Revenue
23.7%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
2.44×
TTM Free Cash FlowTrailing 4 quarters
$229.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PIII
PIII
PRGS
PRGS
Q4 25
$-25.7M
$62.8M
Q3 25
$-15.4M
$73.4M
Q2 25
$-16.6M
$30.0M
Q1 25
$-33.5M
$68.9M
Q4 24
$-57.2M
$19.7M
Q3 24
$-22.6M
$57.7M
Q2 24
$-10.2M
$63.7M
Q1 24
$-20.0M
$70.5M
Free Cash Flow
PIII
PIII
PRGS
PRGS
Q4 25
$59.9M
Q3 25
$72.4M
Q2 25
$29.5M
Q1 25
$67.7M
Q4 24
$16.8M
Q3 24
$56.6M
Q2 24
$62.7M
Q1 24
$70.2M
FCF Margin
PIII
PIII
PRGS
PRGS
Q4 25
23.7%
Q3 25
29.0%
Q2 25
12.4%
Q1 25
28.4%
Q4 24
7.8%
Q3 24
31.7%
Q2 24
35.8%
Q1 24
38.0%
Capex Intensity
PIII
PIII
PRGS
PRGS
Q4 25
1.1%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
0.0%
1.3%
Q3 24
0.0%
0.6%
Q2 24
0.0%
0.5%
Q1 24
0.0%
0.2%
Cash Conversion
PIII
PIII
PRGS
PRGS
Q4 25
2.44×
Q3 25
3.78×
Q2 25
1.76×
Q1 25
6.30×
Q4 24
17.13×
Q3 24
2.03×
Q2 24
3.93×
Q1 24
3.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PIII
PIII

Capitated Revenue$366.2M95%
Health Care Patient Service$18.6M5%
Health Care Care Coordination Management Fees$2.7M1%

PRGS
PRGS

Maintenanceand Services$187.5M74%
Share File Acquisition$67.5M27%

Related Comparisons